Abstract
GLIAL-CELL-LINE-DERIVED neurotrophic factor (GDNF)1 is a potent survival factor for dopaminergic neurons and motor neurons in culture1,2. It also protects these neurons from degeneration in vitro3–9, and improves symptoms like Parkinson's disease induced pharmacologically in rodents10 and monkeys11. Thus GDNF might have beneficial effects in the treatment of Parkinson's disease and amyotrophic lateral sclerosis. To examine the physiological role of GDNF in the development of the mammalian nervous system, we have generated mice defective in GDNF expression by using homologous recombination in embryonic stem cells to delete each of its two coding exons1. GDNF-null mice, regardless of their targeted mutation, display complete renal agenesis owing to lack of induction of the ureteric bud, an early step in kidney development. These mice also have no enteric neurons, which probably explains the observed pyloric stenosis and dilation of their duodenum. However, ablation of the GDNF gene does not affect the differentiation and survival of dopaminergic neurons, at least during embryonic development.
Similar content being viewed by others
References
Lin, L. F. H. et al. Science 260, 1130–1132 (1993).
Henderson, C. E. et al. Science 226, 1062–1064 (1994).
Zurn, A. D. et al. NeuroReport. 6 (1), 113–118 (1994).
Beck, K. D. et al. Nature 373, 339–341 (1995).
Kearns, C. M. & Gash, D. M. Brain Res. 672, 104–111 (1995).
Li, L. X. et al. Proc. natn. Acad. Sci. U.S.A. 92, 9771–9775 (1995).
Oppenheim, R. W. et al. Nature 373, 344–346 (1995).
Tomac, A. et al. Nature 373, 335–339 (1995).
Yan, Q., Matheson, C. & Lopez, O. T. Nature 373, 341–344 (1995).
Hoffer, B. J. et al. Neurosci. Lett. 182 (1), 107–111 (1994).
Gash, M. D. et al. Nature 380, 252–255 (1966).
Hellmich, H. L. et al. Mech. Dev. 54, 95–105 (1996).
Saxen, L. Oiganogenesis of the Kidney Vol. 19 (eds Barlow, P. W., Green, P. B., and Wylie, C. C.) (Cambridge Univ. Press, 1987).
Blaugrund, E. et al. Development 122, 309–320 (1996).
Arenas, E., Trupp, M., Akerud, P. & Ibañez, C. Neuron 15, 1465–1473 (1995).
Schuchardt, A. et al. Nature 367, 380–383 (1994).
Pachnis, V., Mankoo, B. & Costantini, F. Development 119, 1005–1017 (1993).
Durbec, P. L. et al. Development 122, 349–358 (1996).
Torres, M., Gomez-Pardo, E., Dressler, G. R. & Gruss, P. Development 121, 4057–4065 (1995).
Kreidberg, J. A. et al. Cell 74, 679—691 (1993).
Swiatek, P. J. & Gridley, T. Genes Dev 7, 2071–2984 (1993).
Tybulewicz, V. L. et al. Cell 65, 1153–1163 (1991).
Wurst, W. & Joyner, A. L. in Gene Targeting: a Practical Approach (ed. Joyner, A. L.) 33–61 (IRL, Oxford, 1995).
Papaioannou, V. & Johnson, R. in Gene Targeting: a Practical Approach (ed. Joyner, A. L.) 107–146 (IRL, Oxford, 1995).
Gossler, A. & Zachgo, J. in Gene Targeting: a Practical Approach (ed. Joyner, A. L.) 181–225 (IRL, Oxford, 1995).
Butcher, L. L. & Woolf, N. J. in Handbook of Chemical Neuroanatomy Vol II (eds Bjorkland, A., Hokfelt, T. & Kuhar, M. J.) Elsevier, Amsterdam, 1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sánchez, M., Silos-Santiago, I., Frisén, J. et al. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70–73 (1996). https://doi.org/10.1038/382070a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/382070a0
- Springer Nature Limited
This article is cited by
-
Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease
Neurological Sciences (2024)
-
Genomic landscape of 891 RET fusions detected across diverse solid tumor types
npj Precision Oncology (2023)
-
Congenital anomalies of the kidney and urinary tract: defining risk factors of disease progression and determinants of outcomes
Pediatric Nephrology (2023)
-
Stem cell-based therapy for hirschsprung disease, do we have the guts to treat?
Gene Therapy (2022)
-
Hirschsprung’s disease: key microRNAs and target genes
Pediatric Research (2022)